Somatic loss-of-function mutations of PHF6 are most commonly seen in T-cell acute lymphoblastic leukemia (T-ALL) (15% of pediatric cases, 35% of adult cases) and wild-type PHF6 is a known tumor suppressor in T-ALL [2]. Here, PHF6 is linked to acute lymphoblastic leukemia.